查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726210

C反应蛋白检测市场规模、份额、趋势分析报告（按检测类型、检测范围、疾病区域、最终用途、地区和细分市场预测），2025-2030年

C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type (ELISA, CLIA), By Detection Range (hs-CRP, Conventional CRP), By Disease Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 320 Pages | 商品交期: 2-10个工作天内

价格

C反应蛋白检测市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球C反应蛋白（CRP）检测市场规模预计到2030年将达到56.6亿美元，2025年至2030年期间的复合年增长率为0.24%。

C反应蛋白检测的成长得益于旨在探索此检测各种应用的大量研究活动。私人和公共组织提供资金来促进这一领域的研究，进一步推动了这项研究活动。由于奈米技术工具的进步，市场预计将显着增长。这些进步为开发可携式生物分析检测方法提供了良好的机会，这些检测方法具有高特异性、灵敏度、快速反应时间和多路復用能力等特性，可以在护理点进行准确的疾病诊断和监测。

预计这些进步将在预测期内推动 CRP 测试的需求。此外，策略交易和发展的增加以及研发投资的增加也推动了成长。由于 CRP 被认为是评估感染和发炎严重程度的重要生物标记物，因此 COVID-19 大流行对市场产生了相当大的影响。这导致对服务和产品的需求增加。雅培等主要企业正在提供针对 SARS-CoV-2 感染的特定 CRP 检测的支援工具，进一步促进了市场的成长。此外，主要企业越来越关注产品发布和照护现场CRP 测试的开发，预计这将在未来几年进一步推动市场成长。

例如，2022 年 7 月，Bloom Diagnostics 推出了 Bloom 发炎测试，这是一种旨在量化血液中 CRP 水平的半自动化检测套组。此一次性试剂套件有助于检测体内的发炎。预计测试设施的建立将进一步刺激市场成长。 2021 年 6 月，Trivitron 医疗保健推出了用于诊断 COVID-19 的行动侦测实验室，为印度各地（包括农村、都市区和偏远地区）提供检测服务。这个独特的实验室提供各种测试，包括针对 CRP、IL-6 和 D-二聚体等发炎标记物的 CLIA/Elisa 测试、快速抗原测试、RT-PCR 测试以及 CLIA/Elisa 抗体测试 IgM 和 IgG。

2022 年，北美占据了最大的收益占有率，为 39.42%，并且由于心血管疾病患病率的不断上升、产品稳步推出、现有市场参与企业的存在、技术进步以及发达的医疗保健基础设施，预计在预测期内将保持其份额。预计 2023 年至 2030 年间，亚太地区的复合年增长率最快，为 0.49%。 COVID-19 疫情起源于中国。 CRP 测试（一种用于确定感染严重程度的潜在生物标记）的需求预计很快就会增加。全球产业主要企业不断注重产品发布和地理扩张以保持其地位。

C反应蛋白检测市场报告重点

  • 根据检测类型，免疫比浊法测定部分在 2024 年占据了最大的收益占有率，为 48.5%。随着高灵敏度、自动化、经济高效的免疫比浊法测定的推出，该测定方法提供了广泛的测量范围，可以准确检测样品中的 CRP 水平。
  • 以检测范围计算，hs-CRP 细分市场在 2024 年占据市场主导地位，收益占有率约为 42.80%。 hs-CRP比传统CRP有更广的检测范围。
  • 根据治疗领域，心血管疾病领域预计将在 2024 年占据最大的市场占有率，并在整个预测期内占据市场主导地位。心血管疾病 (CVD) 盛行率的不断上升是推动 CRP 检测市场成长的主要因素。
  • 2024 年，医院终端用户部门占据了 28.0% 的市场占有率，这得益于医院对 CRP 检测的采用率增加，尤其是为了应对 COVID-19 疫情。这提高了测试率，促进了该领域的成长。
  • 此外，由于慢性心臟疾病和癌症的发生率不断上升，市场也不断增长。由于在诊断、管理和监测这些疾病方面对 CRP 检测的需求不断增加，这些疾病对市场扩张做出了重大贡献。

目录

第一章调查方法与范围

第二章执行摘要

3. C反应蛋白检测市场变数、趋势和范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • C反应蛋白检测市场分析工具
    • 波特五力分析
    • PESTEL分析

4. C反应蛋白检测市场（依检测类型、估值和趋势分析）

  • C反应蛋白检测市场：检测类型变异分析
  • 免疫比浊法
    • 免疫比浊法市场，2018-2030
  • ELISA
    • ELISA 市场，2018-2030 年
    • 临床ELISA
    • 非临床 ELISA
  • 化学冷光免疫检测
    • 化学冷光免疫检测市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第五章 C反应蛋白检测市场：依检测范围的估计与趋势分析

  • C反应蛋白检测市场：检测范围变化分析
  • 高敏感性C反应蛋白（hs-CRP）
    • 高敏感性C反应蛋白（hs-CRP）市场，2018-2030
  • 常规 CRP
    • 传统CRP市场，2018-2030
  • 心臟C反应蛋白（cCRP）
    • 心臟 CRP (cCRP) 市场，2018-2030 年

6. C反应蛋白检测市场：依疾病领域估计与趋势分析

  • C反应蛋白检测市场：疾病区域变异分析
  • 心血管疾病
    • 2018-2030年心血管疾病市场
  • 癌症
    • 癌症市场，2018-2030
  • 类风湿性关节炎
    • 类风湿性关节炎市场，2018-2030
  • 发炎性肠道疾病
    • 发炎性肠道疾病市场，2018-2030
  • 子宫内膜异位症
    • 子宫内膜异位症市场，2018-2030
  • 狼疮
    • 狼疮市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

7. C反应蛋白检测市场最终用途、估价及趋势分析

  • C反应蛋白检测市场：最终用途变异分析
  • 诊所
    • 诊所市场，2018-2030
    • 诊所和团体
    • 按诊所和环境
  • 医院
    • 医院市场，2018-2030
    • 都市环境
    • 当地环境
  • 实验室
    • 实验室市场，2018-2030
    • 都市环境
    • 当地环境
  • 护理设施
    • 辅助生活市场，2018-2030
    • 都市环境
    • 当地环境
  • 住宅
    • 2018-2030年住宅市场
  • 其他的
    • 其他市场，2018-2030

8. C反应蛋白检测市场：区域、估计和趋势分析

  • C反应蛋白检测市场占有率（2024年及2030年，百万美元）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
  • Abbott
    • 参与企业概况
    • 近期趋势/策略倡议
  • Siemens Healthineers AG
    • 参与企业概况
    • 近期趋势/策略倡议
  • Danaher Corporation
    • 参与企业概况
    • 近期趋势/策略倡议
  • Quest Diagnostics
    • 参与企业概况
    • 近期趋势/策略倡议
  • Siemens Healthineers AG
    • 参与企业概况
    • 近期趋势/策略倡议
  • Abbott
    • 参与企业概况
    • 近期趋势/策略倡议
  • Merck KGaAA
    • 参与企业概况
    • 近期趋势/策略倡议
  • Zoetis
    • 参与企业概况
    • 近期趋势/策略倡议
  • F. Hoffmann-La Roche AG
    • 参与企业概况
    • 近期趋势/策略倡议
  • Ortho Clinical Diagnostics
    • 参与企业概况
    • 近期趋势/策略倡议
  • Thermo Fisher Scientific, Inc.
    • 参与企业概况
    • 近期趋势/策略倡议
  • HORIBA, Ltd
    • 参与企业概况
    • 近期趋势/策略倡议
  • Randox Laboratories Ltd.
    • 参与企业概况
    • 近期趋势/策略倡议
  • Boditech Med, Inc.
    • 参与企业概况
    • 近期趋势/策略倡议
  • Aidian
    • 参与企业概况
    • 近期趋势/策略倡议
Product Code: GVR-2-68038-129-0

C-Reactive Protein Testing Market Growth & Trends:

The global C-reactive protein testing market size is expected to reach USD 5.66 billion by 2030 and is projected to grow at a CAGR of 0.24% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of C-reactive protein (CRP) testing can be attributed to significant research activities aimed at exploring various applications of testing. These research efforts are further facilitated by the presence of both private and public agencies that provide funding to expedite research in this field. The market is anticipated to witness significant growth owing to advancements in nanotechnological tools. These advancements offer promising opportunities to develop portable bioanalytical assays that possess attributes, such as high specificity, sensitivity, rapid response time, and the ability to perform multiplexing for accurate disease diagnosis and monitoring at the point of care.

These advancements are expected to drive the demand for CRP testing during the forecast period. Furthermore, an increase in strategic deals and developments, as well as higher investments in research and development has fueled the growth. The COVID-19 pandemic has had a considerable impact on the market, as CRP is considered a crucial biomarker for assessing the severity of infection and inflammation. As a result, there is an increased demand for services and products. Leading companies, such as Abbott, provide supportive tools for CRP testing specifically for SARS-CoV-2 infection, further contributing to market growth. Moreover, key players increased focus on product launches and developments in point-of-care CRP tests, which is projected to further fuel the market's growth in the coming years.

For instance, in July 2022, Bloom Diagnostics introduced the Bloom Inflammation Test, a semi-automated testing kit designed for the quantification of CRP levels in the blood. This single-use kit aids in the detection of inflammation within the body. The growth of the marketplace is expected to be further stimulated by the establishment of testing facilities. In June 2021, Trivitron Healthcare unveiled a mobile laboratory for COVID-19 diagnostics, enabling testing services in various regions of India, including rural, urban, and remote areas. This indigenous laboratory offers a range of tests, including CLIA/Elisa tests for inflammatory markers, such as a CRP, IL-6, and D-Dimer, as well as rapid antigen tests, RT-PCR tests, CLIA/Elisa Antibodies Tests IgM and IgG, and others.

North America held the largest revenue share of 39.42% in 2022 and is expected to maintain its share during the forecast period due to the increasing prevalence of cardiovascular diseases, a steady stream of product launches, presence of established market players, technological advancements, and well-developed healthcare infrastructure. Asia Pacific is projected to grow at the fastest CAGR of 0.49% from 2023 to 2030. The COVID-19 pandemic originated in China. Being the potential biomarker for determining the severity of the infection, the demand for CRP testing is expected to increase shortly. Key players operating in the global industry are constantly focusing on product launches and geographical expansion to maintain their presence.

C-Reactive Protein Testing Market Report Highlights:

  • Based on assay type, the immunoturbidimetric assay segment held the largest revenue share of 48.5% in 2024. Owing to the introduction of a highly sensitive, automated, and cost-effective immunoturbidimetric assay that offers a wide measuring range for accurately detecting the levels of CRP in samples
  • Based on detection ranges, the hs-CRP segment dominated the market in 2024 with a revenue share of approximately 42.80%. The hs-CRP features a broad detection range than that compared to the conventional CRP
  • Based on disease area type, the cardiovascular diseases segment dominated the market with the largest market share in 2024 and is anticipated to dominate the market throughout the forecast period. The increase in the prevalence of CVDs is the major factor contributing to the growth of the CRP testing market
  • The hospitals end-user segment dominated with a market share of 28.0% in 2024 due to the increased adoption of CRP testing in hospitals, particularly in response to the COVID-19 pandemic. This has led to a higher testing rate and contributed to the segment's growth
  • Furthermore, the marketplace is experiencing growth due to the increasing prevalence of chronic heart diseases and cancers. These conditions contribute significantly to the market's expansion as there is a rising demand for CRP testing in the diagnosis, management, and monitoring of these diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Assay Type
    • 1.2.2. Detection Range
    • 1.2.3. Disease Type
    • 1.2.4. End Use
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. C-Reactive Protein Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising incidence of chronic and infectious diseases
      • 3.3.1.2. Increasing demand for point-of-care diagnostics
      • 3.3.1.3. Growing demand for portable and automated C-reactive proteins
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Lower detection limit
      • 3.3.2.2. Limitations associated with C-reactive protein techniques
  • 3.4. C-Reactive Protein Testing Market Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. C-Reactive Protein Testing Market: Assay Type Estimates & Trend Analysis

  • 4.1. C-reactive Protein (CRP) Testing Market: Assay Type Movement Analysis
  • 4.2. Immunoturbidimetric Assay
    • 4.2.1. Immunoturbidimetric Assay Market, 2018 - 2030 (USD Million)
  • 4.3. ELISA
    • 4.3.1. ELISA Market, 2018 - 2030 (USD Million)
    • 4.3.2. Clinical ELISA
      • 4.3.2.1. Clinical ELISA Market, 2018 - 2030 (USD Million)
    • 4.3.3. Nonclinical ELISA
      • 4.3.3.1. Nonclinical ELISA Market, 2018 - 2030 (USD Million)
  • 4.4. Chemiluminescence Immunoassay
    • 4.4.1. Chemiluminescence Immunoassay Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. C-Reactive Protein Testing Market: Detection Range Estimates & Trend Analysis

  • 5.1. C-reactive Protein (CRP) Testing Market: Detection Range Movement Analysis
  • 5.2. High Sensitivity C-reactive Protein (hs-CRP)
    • 5.2.1. High Sensitivity C-reactive Protein (hs-CRP) Market, 2018 - 2030 (USD Million)
  • 5.3. Conventional CRP
    • 5.3.1. Conventional CRP Market, 2018 - 2030 (USD Million)
  • 5.4. Cardiac CRP (cCRP)
    • 5.4.1. Cardiac CRP (CCRP) Market, 2018 - 2030 (USD Million)

Chapter 6. C-Reactive Protein Testing Market Disease Area Estimates & Trend Analysis

  • 6.1. C-reactive Protein (CRP) Testing Market: Disease Area Movement Analysis
  • 6.2. Cardiovascular Diseases
    • 6.2.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
  • 6.3. Cancer
    • 6.3.1. Cancer Market, 2018 - 2030 (USD Million)
  • 6.4. Rheumatoid Arthritis
    • 6.4.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
  • 6.5. Inflammatory Bowel Disease
    • 6.5.1. Inflammatory Bowel Disease Market, 2018 - 2030 (USD Million)
  • 6.6. Endometriosis
    • 6.6.1. Endometriosis Market, 2018 - 2030 (USD Million)
  • 6.7. Lupus
    • 6.7.1. Lupus Market, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. C-Reactive Protein Testing Market End Use Estimates & Trend Analysis

  • 7.1. C-reactive Protein (CRP) Testing Market: End-use Movement Analysis
  • 7.2. Clinics
    • 7.2.1. Clinics Market, 2018 - 2030 (USD Million)
    • 7.2.2. Clinics, by entity
      • 7.2.2.1. Physician offices
        • 7.2.2.1.1. Physician Offices Market, 2018 - 2030 (USD Million)
      • 7.2.2.2. Small clinics
        • 7.2.2.2.1. Small Clinics Market, 2018 - 2030 (USD Million)
      • 7.2.2.3. Others
        • 7.2.2.3.1. Others Market, 2018 - 2030 (USD Million)
    • 7.2.3. Clinics, by setting
      • 7.2.3.1. Urban setting
        • 7.2.3.1.1. Urban Setting Market, 2018 - 2030 (USD Million)
      • 7.2.3.2. Rural settings
        • 7.2.3.2.1. Rural Settings Market, 2018 - 2030 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market, 2018 - 2030 (USD Million)
    • 7.3.2. Urban setting
      • 7.3.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
    • 7.3.3. Rural settings
      • 7.3.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
  • 7.4. Laboratories
    • 7.4.1. Laboratories Market, 2018 - 2030 (USD Million)
    • 7.4.2. Urban setting
      • 7.4.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
    • 7.4.3. Rural settings
      • 7.4.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
  • 7.5. Assisted Living Healthcare Facilities
    • 7.5.1. Assisted Living Healthcare Facilities Market, 2018 - 2030 (USD Million)
    • 7.5.2. Urban setting
      • 7.5.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
    • 7.5.3. Rural settings
      • 7.5.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
  • 7.6. Home
    • 7.6.1. Home Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. C-Reactive Protein Testing Market: Regional Estimates & Trend Analysis

  • 8.1. C-Reactive Protein Testing Market Share, By Region, 2024 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. Regulatory Framework
      • 8.2.2.5. Reimbursement Scenario
      • 8.2.2.6. U.S. C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. Canada C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Mexico C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. Reimbursement Scenario
      • 8.3.2.6. UK C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. France C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. Italy C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Spain C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Denmark C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Sweden C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Norway C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Reimbursement Scenario
      • 8.4.2.6. Japan C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. China C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. India C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. Australia C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. South Korea C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Thailand C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Reimbursement Scenario
      • 8.5.2.6. Brazil C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Argentina C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Reimbursement Scenario
      • 8.6.2.6. South Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. Saudi Arabia C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. UAE C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. Kuwait C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
  • 9.5. Abbott
    • 9.5.1. Participant's Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Developments/ Strategic Initiatives
  • 9.6. Siemens Healthineers AG
    • 9.6.1. Participant's Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Developments/ Strategic Initiatives
  • 9.7. Danaher Corporation
    • 9.7.1. Participant's Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Developments/ Strategic Initiatives
  • 9.8. Quest Diagnostics
    • 9.8.1. Participant's Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Developments/ Strategic Initiatives
  • 9.9. Siemens Healthineers AG
    • 9.9.1. Participant's Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Developments/ Strategic Initiatives
  • 9.10. Abbott
    • 9.10.1. Participant's Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Developments/ Strategic Initiatives
  • 9.11. Merck KGaAA
    • 9.11.1. Participant's Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Developments/ Strategic Initiatives
  • 9.12. Zoetis
    • 9.12.1. Participant's Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Developments/ Strategic Initiatives
  • 9.13. F. Hoffmann-La Roche AG
    • 9.13.1. Participant's Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Developments/ Strategic Initiatives
  • 9.14. Ortho Clinical Diagnostics
    • 9.14.1. Participant's Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Developments/ Strategic Initiatives
  • 9.15. Thermo Fisher Scientific, Inc.
    • 9.15.1. Participant's Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Developments/ Strategic Initiatives
  • 9.16. HORIBA, Ltd
    • 9.16.1. Participant's Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Developments/ Strategic Initiatives
  • 9.17. Randox Laboratories Ltd.
    • 9.17.1. Participant's Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Developments/ Strategic Initiatives
  • 9.18. Boditech Med, Inc.
    • 9.18.1. Participant's Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Recent Developments/ Strategic Initiatives
  • 9.19. Aidian
    • 9.19.1. Participant's Overview
    • 9.19.2. Financial Performance
    • 9.19.3. Product Benchmarking
    • 9.19.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global C-reactive protein market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 4 Global C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 5 Global C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 6 Global C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 9 North America C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 10 North America C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 11 North America C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 13 U.S. C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 14 U.S. C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 15 U.S. C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 17 Canada C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 18 Canada C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 19 Canada C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Mexico C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 21 Mexico C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Mexico C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 23 Mexico C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 26 Europe C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 27 Europe C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 28 Europe C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 UK C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 30 UK C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 31 UK C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 32 UK C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Germany C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 34 Germany C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 35 Germany C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 36 Germany C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 France C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 38 France C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 39 France C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 40 France C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Italy C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 42 Italy C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 43 Italy C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 44 Italy C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Spain C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 46 Spain C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 47 Spain C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 48 Spain C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Denmark C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 50 Denmark C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 51 Denmark C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 52 Denmark C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Sweden C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 54 Sweden C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 55 Sweden C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 56 Sweden C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Norway C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 58 Norway C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 59 Norway C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 60 Norway C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Japan C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 67 Japan C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 68 Japan C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 69 Japan C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 China C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 71 China C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 72 China C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 73 China C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 India C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 75 India C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 76 India C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 77 India C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Australia C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 79 Australia C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 80 Australia C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 81 Australia C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Korea C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 83 South Korea C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 84 South Korea C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 85 South Korea C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Thailand C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 87 Thailand C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 88 Thailand C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 89 Thailand C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Latin America C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 92 Latin America C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 93 Latin America C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 94 Latin America C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Brazil C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 96 Brazil C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 97 Brazil C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 98 Brazil C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 100 Argentina C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 101 Argentina C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 102 Argentina C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA C-reactive protein market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 105 MEA C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 106 MEA C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 107 MEA C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 109 South Africa C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 110 South Africa C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 111 South Africa C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 117 UAE C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 118 UAE C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 119 UAE C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
  • Table 123 Kuwait C-reactive protein market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 C-reactive protein testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 C-reactive protein testing market: Assay type outlook key takeaways
  • Fig. 20 C-reactive protein testing market: Assay type movement analysis
  • Fig. 21 Immunoturbidimetric assay market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 22 ELISA market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 23 Chemiluminescence Immunoassay (CLIA ) market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 24 Other Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 25 C-reactive protein market: Detection Range outlook key takeaways
  • Fig. 26 C-reactive protein market: Detection Range movement analysis
  • Fig. 27 hs-CRP market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 28 Conventional CRP market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 29 cCRP market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 30 C-reactive protein market: Disease Type outlook key takeaways
  • Fig. 31 C-reactive protein market: Disease Type movement analysis
  • Fig. 32 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 33 Cancer market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 34 Rheumatoid arthritis market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 35 Inflammatory bowel disease Testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 36 Endometriosis market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 37 Lupus market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 39 C-reactive protein market: End-use outlook key takeaways
  • Fig. 40 C-reactive protein market: End-use movement analysis
  • Fig. 41 Hospitals market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 42 Clinics market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 43 Physician Office clinics market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 44 Small clinics market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 45 Others clinics market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 46 Laboratories market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 47 Assisted living healthcare facilities market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 48 Home market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 49 Others market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 50 Regional marketplace outlook, 2024 & 2030 (USD million)
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 53 Key country dynamics
  • Fig. 54 U.S. C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Canada C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Mexico C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 59 Europe C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 60 Key country dynamics
  • Fig. 61 UK C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Germany C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 64 Key country dynamics
  • Fig. 65 France C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Spain C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Denmark C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Sweden C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Norway C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 76 Asia Pacific C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Japan C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 79 Key country dynamics
  • Fig. 80 China C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 81 Key country dynamics
  • Fig. 82 India C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Australia C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Korea C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Thailand C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Market participant categorization
  • Fig. 91 C-reactive protein testing market position analysis, 2023
  • Fig. 92 Strategic framework